CalciMedica, Inc. (CALC) announced it has regained compliance with a Nasdaq listing requirement related to the minimum market value of its listed securities (MVLS). Nasdaq has closed the matter after determining the company satisfies the alternative minimum stockholders' equity requirement. A separate notice regarding the minimum bid price requirement remains active.
Key Details
- Compliance Regained: On August 31, 2026, Nasdaq confirmed that CalciMedica complies with the alternative stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1), resolving a previous deficiency notice from March 13, 2026.
- Stockholders' Equity: The determination was based on the company's reported stockholders' equity of $5,513,000 as of June 30, 2026.
- Outstanding Issue: The company is still not in compliance with Nasdaq's $1.00 minimum bid price rule and has until September 14, 2026, to regain compliance. A 1-for-5 reverse stock split was implemented on August 28, 2026, to address this.